Resistance Training in Lung Cancer Patients on Chemotherapy
The purpose of this study is to examine the effectiveness of a resistance training program on reducing systemic inflammation and improving chemotherapy completion in lung cancer patients being treated with curative intent chemotherapy.
Checked against the public recordLast updated Aug 20, 2015 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- East Carolina University
- Interventions being studied
- Behavioral: Exercise
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Histologically diagnosed with lung cancer * Stage I, II, or III * Eligible for chemotherapy with curative intent * 21 years of age or older * Approval to participate in study by treating oncologist or family physician Exclusion Criteria: * Unstable cardiac disease * Untreated bone or brain metastases
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Leo Jenkins Cancer CenterGreenville, North Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 20, 2015. Always confirm current availability with the study team.